* LifeMD Inc LFMD.OQ LFMD.O is expected to show a rise
in
quarterly revenue when it reports results on August 11.
* The New York City-based company is expected to report a
43.3% increase in revenue to $31.965 million from $22.31 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for LifeMD Inc is for a
loss
of 35 cents per share. For the same quarter last year, the
company reported a loss of 64 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LifeMD Inc
is
$8, above its last closing price of $2.94.
This summary was machine generated August 10 at 02:04 GMT. All
figures in US dollars unless otherwise stated